1. Phase II evaluation of aclarubicin in refractory adult acute leukemia: A Southwest Oncology Group Study;Dabich;Cancer Treatment Reports,1986
2. Plasma kinetics of aclacinomycin A and its major metabolites in man;Egorin;Cancer Chemotherapy and Pharmacology,1982
3. Purification and characterization of aclacinomycin A and its metabolites from human urine;Egorin;Drug Metabolism and Disposition,1983
4. Aclarubicin in the treatment of advanced gastrointestinal adenocarcinoma;Elomaa;Acta Oncologica,1990
5. The antitumor drug aclacinomycin A which inhibits the degradation of ubiquitinated proteins shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20S proteasome;Figueiredo-Pereira;The Journal of Biological Chemistry,1996